Loading...
Loading...
Of the 2 tracked institutions holding BRNS, 2 have a 3-year clone track record — 2 of them beat the S&P. Average holder's clone alpha: +8.4pt. It's a gauge of who owns the name, not just how many.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Among the 2 tracked institutional investors we monitor, BRNS (BARINTHUS BIOTHERAPEUTICS PL) is held with a combined value of $154.04K across 269,996 shares. The largest holder is RENAISSANCE TECHNOLOGIES LLC with a position worth $85.92K. 2 funds increased their holdings.
Total Institutional Value
$154.04K
Total Shares Held
269,996
Institutional Holders
2
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | $85.92K | 0.00% | +5.5% |
| 2 | CITADEL ADVISORS LLC | $68.13K | 0.00% | +0.2% |
As of the latest SEC 13F filings, RENAISSANCE TECHNOLOGIES LLC is the largest institutional holder of BRNS with a position worth $85.92K, representing 0.00% of their portfolio. In total, 2 institutional investors hold BRNS with a combined value of $154.04K.
Institutional investors hold $154.04K worth of BRNS stock across 2 positions. The largest institutional holder is RENAISSANCE TECHNOLOGIES LLC with $85.92K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For BRNS, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their BRNS positions.
Last Close
$0.60
2026-07-24
YTD
-18.1%
4% of 52-week range
